A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to mRNA-1010
Related studies linked through entity extraction aliases.
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE2
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
- Status
- COMPLETED
- Phase
- PHASE3
A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE2
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old
- Status
- COMPLETED
- Phase
- PHASE1
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
- Status
- COMPLETED
- Phase
- PHASE3
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Modified mRNA Vaccines in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2